Home ETF List About

Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / FundiShares US Medical Devices UCITS ETF
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerUMDV.AS(USD) CXE
ETF TickerUMDV(USD) Euronext Amsterdam

Holdings detail for TMCI

Stock NameTreace Medical Concepts Inc
TickerTMCI(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS89455T1097

Show aggregate TMCI holdings

News associated with TMCI

Head-To-Head Survey: Treace Medical Concepts (NASDAQ:TMCI) versus Nihon Kohden (OTCMKTS:NHNKY)
Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) and Treace Medical Concepts (NASDAQ:TMCI – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation. Risk and Volatility Nihon Kohden has […] - 2025-08-31 05:50:53
Stifel Nicolaus Cuts Treace Medical Concepts (NASDAQ:TMCI) Price Target to $6.00
Treace Medical Concepts (NASDAQ:TMCI – Free Report) had its price objective cut by Stifel Nicolaus from $9.00 to $6.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have a hold rating on the stock. Other equities analysts have also issued reports about the company. UBS Group reduced their price target […] - 2025-08-11 03:42:56
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) PT at $10.52
Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) have been given an average rating of “Hold” by the six brokerages that are currently covering the stock, MarketBeat reports. Four analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month target […] - 2025-08-04 02:26:49
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Target Price at $10.16
Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) have earned a consensus rating of “Hold” from the seven research firms that are currently covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1-year […] - 2025-07-10 02:34:50
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Recommendation of “Hold” by Analysts
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) has earned a consensus rating of “Hold” from the seven analysts that are currently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1-year target price among […] - 2025-06-12 04:56:54
Squarepoint Ops LLC Sells 52,890 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Squarepoint Ops LLC lowered its stake in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 74.1% during the 4th quarter, Holdings Channel.com reports. The fund owned 18,470 shares of the company’s stock after selling 52,890 shares during the quarter. Squarepoint Ops LLC’s holdings in Treace Medical Concepts were worth $137,000 as of […] - 2025-06-10 04:25:03
Two Sigma Investments LP Sells 7,346 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Two Sigma Investments LP decreased its position in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 4.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 153,824 shares of the company’s stock after selling 7,346 shares during the period. Two Sigma […] - 2025-06-05 04:44:59
13,739 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Purchased by ProShare Advisors LLC
ProShare Advisors LLC bought a new position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm bought 13,739 shares of the company’s stock, valued at approximately $102,000. Several other institutional investors have also recently made changes to their positions in the business. MIRAE ASSET […] - 2025-06-04 04:40:51
Analysts See 14% Gains Ahead For The Holdings of IHI
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-23 07:36:08
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) PT at $10.16
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) has received an average rating of “Hold” from the seven research firms that are currently covering the company, MarketBeat.com reports. Five investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price target […] - 2025-05-21 03:14:50
Balyasny Asset Management L.P. Sells 189,380 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Balyasny Asset Management L.P. reduced its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 94.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,723 shares of the company’s stock after selling 189,380 shares during the period. Balyasny […] - 2025-05-19 04:52:49
Wells Fargo & Company MN Raises Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Wells Fargo & Company MN boosted its position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 45.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 24,796 shares of the company’s stock after acquiring an additional 7,769 shares during […] - 2025-05-09 04:18:47
Stifel Financial Corp Buys 55,540 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Stifel Financial Corp lifted its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 41.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 189,301 shares of the company’s stock after acquiring an additional 55,540 shares during the period. […] - 2025-05-08 05:16:52
Marshall Wace LLP Has $661,000 Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Marshall Wace LLP decreased its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 79.2% during the 4th quarter, HoldingsChannel reports. The fund owned 88,910 shares of the company’s stock after selling 337,820 shares during the period. Marshall Wace LLP’s holdings in Treace Medical Concepts were worth $661,000 as of its most recent […] - 2025-05-02 05:32:47
Legal & General Group Plc Sells 36,793 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Legal & General Group Plc trimmed its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 87.2% during the 4th quarter, Holdings Channel reports. The firm owned 5,423 shares of the company’s stock after selling 36,793 shares during the quarter. Legal & General Group Plc’s holdings in Treace Medical Concepts were worth $40,000 […] - 2025-05-02 04:40:55
Vanguard Group Inc. Has $20.33 Million Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Vanguard Group Inc. lowered its position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 0.3% during the fourth quarter, Holdings Channel reports. The fund owned 2,732,585 shares of the company’s stock after selling 8,903 shares during the quarter. Vanguard Group Inc.’s holdings in Treace Medical Concepts were worth $20,330,000 at the […] - 2025-04-16 04:28:49
ExodusPoint Capital Management LP Invests $251,000 in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
ExodusPoint Capital Management LP bought a new stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 33,721 shares of the company’s stock, valued at approximately $251,000. ExodusPoint Capital Management LP owned […] - 2025-04-14 05:27:05
Truist Financial Issues Pessimistic Forecast for Treace Medical Concepts (NASDAQ:TMCI) Stock Price
Treace Medical Concepts (NASDAQ:TMCI – Free Report) had its price target lowered by Truist Financial from $9.50 to $8.00 in a report released on Friday,Benzinga reports. The firm currently has a hold rating on the stock. A number of other equities research analysts have also issued reports on TMCI. Lake Street Capital initiated coverage on […] - 2025-04-14 02:44:52
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.14 Average PT from Brokerages
Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) have received a consensus rating of “Hold” from the seven research firms that are currently covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 […] - 2025-04-01 02:24:58
Bank of New York Mellon Corp Has $937,000 Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Bank of New York Mellon Corp boosted its holdings in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 2.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 125,945 shares of the company’s stock after acquiring an additional 3,215 shares during the period. Bank of New York Mellon Corp’s holdings in […] - 2025-03-26 05:10:45
Connor Clark & Lunn Investment Management Ltd. Takes $342,000 Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 45,923 shares of the company’s stock, valued at approximately $342,000. A number of other large investors […] - 2025-03-24 05:56:54

iShares US Medical Devices UCITS ETF TMCI holdings

DateNumber of TMCI Shares HeldBase Market Value of TMCI SharesLocal Market Value of TMCI SharesChange in TMCI Shares HeldChange in TMCI Base ValueCurrent Price per TMCI Share HeldPrevious Price per TMCI Share Held
2025-09-26 (Friday)6,133USD 40,846USD 40,846
2025-09-25 (Thursday)6,133USD 40,968USD 40,968
2025-09-24 (Wednesday)5,733USD 38,870USD 38,870
2025-09-18 (Thursday)5,733USD 41,220TMCI holding increased by 860USD 41,2200USD 860 USD 7.18995 USD 7.03994
2025-09-17 (Wednesday)5,733USD 40,360TMCI holding decreased by -172USD 40,3600USD -172 USD 7.03994 USD 7.06995
2025-09-16 (Tuesday)5,733USD 40,532USD 40,532
2025-09-15 (Monday)5,733USD 41,392USD 41,392
2025-09-12 (Friday)5,733USD 41,392USD 41,392
2025-09-11 (Thursday)5,733USD 42,654USD 42,654
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TMCI by Blackrock for IE00BMX0DF60

Show aggregate share trades of TMCI

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-06-27SELL-110 5.750* 7.55 Profit of 831 on sale
2025-06-12BUY159 5.870* 7.68
2025-06-10SELL-816 6.170* 7.70 Profit of 6,282 on sale
2025-06-09SELL-988 5.900* 7.71 Profit of 7,619 on sale
2025-05-30SELL-98 5.740* 7.81 Profit of 765 on sale
2025-05-19BUY49 6.730* 7.93
2025-05-09SELL-285 6.820* 7.99 Profit of 2,278 on sale
2025-04-23SELL-57 6.410* 8.10 Profit of 462 on sale
2025-04-17SELL-57 6.450* 8.18 Profit of 466 on sale
2025-04-10BUY456 6.990* 8.26
2025-04-04SELL-114 7.750* 8.30 Profit of 946 on sale
2025-04-02SELL-114 8.320* 8.30 Profit of 946 on sale
2025-03-31SELL-171 8.390* 8.30 Profit of 1,419 on sale
2025-03-19SELL-51 8.210* 8.28 Profit of 422 on sale
2025-02-28SELL-100 8.940* 8.25 Profit of 825 on sale
2025-02-05BUY171 10.540* 7.62
2025-02-04BUY228 10.510* 7.56
2025-01-29SELL-57 10.420* 7.31 Profit of 417 on sale
2025-01-23SELL-57 9.360* 7.07 Profit of 403 on sale
2025-01-02SELL-99 7.870* 7.05 Profit of 698 on sale
2024-12-04BUY135 8.060* 6.91
2024-12-03SELL-50 8.550* 6.85 Profit of 343 on sale
2024-12-02SELL-600 8.780* 6.78 Profit of 4,069 on sale
2024-11-29SELL-1,040 8.520* 6.72 Profit of 6,985 on sale
2024-11-27SELL-153 8.560* 6.57 Profit of 1,005 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TMCI

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1954,992077,94670.6%
2025-09-1836,961066,94755.2%
2025-09-1752,380087,02160.2%
2025-09-1637,5531,86260,19662.4%
2025-09-1526,714070,47137.9%
2025-09-1241,016080,90350.7%
2025-09-1153,705088,56160.6%
2025-09-1042,0430102,23541.1%
2025-09-0966,7180142,60146.8%
2025-09-0842,675073,77257.8%
2025-09-0548,768075,78264.4%
2025-09-0455,633089,58462.1%
2025-09-0388,4520141,21962.6%
2025-09-0235,988071,71350.2%
2025-08-2937,650058,29764.6%
2025-08-2830,956054,84356.4%
2025-08-2791,149612123,12174.0%
2025-08-2649,782081,90460.8%
2025-08-2539,2387,04265,02260.3%
2025-08-2274,1250111,19166.7%
2025-08-2198,5100184,60353.4%
2025-08-2089,275533153,48158.2%
2025-08-1980,2471,087122,15865.7%
2025-08-1841,61360576,64554.3%
2025-08-15147,8970212,30869.7%
2025-08-1454,5140102,22653.3%
2025-08-1395,91810,250218,26243.9%
2025-08-1273,1472,800136,14353.7%
2025-08-11106,6460167,04963.8%
2025-08-08192,40760369,75952.0%
2025-08-0744,452084,53552.6%
2025-08-0648,4270104,75146.2%
2025-08-0528,671065,35443.9%
2025-08-0432,63316689,23836.6%
2025-08-0132,40030107,36830.2%
2025-07-3165,0570161,29340.3%
2025-07-3023,595083,47528.3%
2025-07-2919,9730120,99116.5%
2025-07-2812,144057,54421.1%
2025-07-2520,046060,02933.4%
2025-07-2417,782033,51453.1%
2025-07-2340,837067,97760.1%
2025-07-2238,058081,77946.5%
2025-07-2143,345060,49771.6%
2025-07-1830,898046,39566.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.